Tailor-Made: Individualizing Type 2 Diabetes Management with GLP-1 Receptor Agonists

In Collaboration With The Academy of Physician Associates in Cardiology (APAC) and The American Society of Endocrine Physician Assistants (ASEPA)

This series features multiple activities aimed at disseminating the latest advances in GLP-1 receptor agonists in diabetes, including a live multidisciplinary panel discussion on how to incorporate this information into daily clinical practice.

Register For the Live Webinar:

Wednesday, July 13, 2022 | COMPLETED

Development Widget